Pharmaceutical Cartridges Market Trends

Global Pharmaceutical Cartridges Market Overview

Pharmaceutical Cartridges Market Size was valued at USD 1.5 billion in 2022 and is projected to grow from USD 1.55 Billion in 2023 to USD 2.06 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.60% during the forecast period (2023 - 2032). Growth in customer preference for proper packaging, increased need for safe pharmaceutical packaging for medications, and supportive government initiatives are the key market drivers enhancing the market growth.

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Pharmaceutical Cartridges Market Trends

• Growing market demand for cartridges is driving the market growth

Prefilled syringes were once the widely used and preferred options among medical professionals. However, accidents involving needle sticks would frequently happen to users. Therefore, packing needs to be secure and easy to use. Since cartridges don't have any needles, there is no chance of damage. Additionally, due to their preservation properties, pharmaceutical cartridges are perfect for temperature-sensitive pharmaceutical goods. Users have a safer option than pharmaceutical packaging using pharmaceutical cartridges. Consequently, the demand for effective compliance packaging is anticipated to create market prospects for pharmaceutical cartridges.

Patients are given parenteral medications when oral medicine administration is challenging or intravenous delivery is the only option. Chronic disorders, including cancer, diabetes, renal failure, hepatic failure, and chronic intestinal conditions, must be treated with parenteral drugs. As the prevalence of chronic diseases increases globally, there is an increase in the demand for parenteral drugs. As a result, parenteral packing demand is rising, which is improving the outlook for the pharmaceutical cartridge industry. Chronic illnesses, also known as non-communicable diseases (NCDs), develop gradually over time due to various environmental, genetic, and behavioral factors. Non-communicable diseases (NCDs) account for 41 million annual deaths, or 74% of all fatalities worldwide, according to the WHO. Seventeen million people worldwide pass away from an NCD before they turn 70 each year; 86% of these untimely deaths occur in low- and middle-income nations. The majority of NCDs, or 17.9 million fatalities each year, are caused by cardiovascular illnesses, followed by malignancies (9.3 million), chronic respiratory conditions (4.1 million), and diabetes (2.0 million, including deaths from renal disease brought on by diabetes). Key elements of the approach to NCDs include palliative care, NCD detection, screening, and therapy. Thus, such rising prevalence is driving the Pharmaceutical Cartridges market revenue.

Pharmaceutical Cartridges Market Segment Insights

Pharmaceutical Cartridges Material Insights

Based on Material, the Pharmaceutical Cartridges Market segmentation includes Glass and Plastic. The Glass segment dominated the market, accounting for 55%-60% of market revenue (78.48 billion). Product demand has increased due to superior quality and damage resistance. Glass cartridge demand is also anticipated to be fueled by its exact dimensional tolerances, resilience to thermal stress, reliable integration with injection machines, and small cosmetic tolerances.

Pharmaceutical Cartridges Capacity Insights

Based on Capacity, the Pharmaceutical Cartridges Market segmentation includes Below 5 ml, 5-50 ml, 51-250 ml, and Above 250 ml. The 5-50 ml category generated the most income (70.4%). To precisely measure and administer liquid pharmaceuticals and other liquids in a safe and controlled way, use a 5 ml–50 ml glass pharmaceutical cartridge. The cartridge aids in ensuring that the proper dosage of medication is given, as well as the safe storage and anti-contamination of the liquid. This kind of cartridge is frequently used in settings where precision and safety are crucial, including hospitals and pharmacies. In addition, the glass cartridge is frequently reusable, making it a cost-effective option for many pharmaceutical and medical applications.

Figure 1: Pharmaceutical Cartridges Market, by Capacity, 2022 & 2032 (USD billion)

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Pharmaceutical Cartridges Regional Insights

By Region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific Pharmaceutical Cartridges market area will dominate this market. In the Asia Pacific region, developing nations like China and India account for around 60% of the market for pharmaceutical cartridges. The market in the Asia Pacific is expanding due to the rising demand for pharmaceutical products and the arrival of numerous local and international pharmaceutical firms in these areas. An increase in healthcare awareness also drives the demand for pharmaceutical cartridges in the area. Moreover, China’s Pharmaceutical Cartridges market held the largest market share, and the Indian Pharmaceutical Cartridges market was the fastest-growing market in the Asia-Pacific region.

Further, the major countries studied in the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: PHARMACEUTICAL CARTRIDGES MARKET SHARE BY REGION 2022 (%)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Pharmaceutical Cartridges market accounts for the second-largest market share. Pharmaceutical cartridges are frequently used to deliver insulin due to their benefits, including long-term storage and precise dose. Additionally, the increased attention businesses in Europe pay to produce glass cartridges due to their growing use in pharmaceutical packaging will be advantageous for the region's development. Further, the German Pharmaceutical Cartridges market held the largest market share, and the UK Pharmaceutical Cartridges market was the fastest growing market in the European region

The North America Pharmaceutical Cartridges Market, is expected to grow at the fastest CAGR from 2023 to 2032. An increase in the prevalence of chronic disorders including diabetes and arthritis, drives the demand for pharmaceutical cartridges in North American nations. The developed healthcare and pharmaceutical sectors and high spending in nations like the United States and Canada are also contributing to the expansion of the regional market. Furthermore, popular biotech and biopharma firms are also boosting market demand.

Pharmaceutical Cartridges Key Market Players & Competitive Insights

Leading market players are investing heavily in R&D to expand their product lines. Companies are also undertaking strategic initiatives to expand their global market share, with important market developments including product/service launches, geographic growth, strategic alliances, partnerships, mergers, and acquisitions. The Pharmaceutical Cartridges industry must provide cost-effective products to grow and survive in a more competitive market climate.

One of the key business strategies companies use in the global Pharmaceutical Cartridges industry is manufacturing in developing countries owing to lower labor and raw material costs. Major pharmaceutical cartridges market players include Ambica Pharma Machines Pvt. Ltd., AptarGroup Inc., Baxter International Inc., Camfil AB, Datwyler Holding Inc., Gerresheimer AG, Groninger, and co. gmbh, Hubena, Kalbag Filters Pvt. Ltd., KEL INDIA FILTERS, Maquinaria Industrial Dara SL, Merck KGaA, Nipro Corp., SCHOTT AG, and SGD S.A.

The company Baxter International Inc. sells a variety of medical supplies. Dialysis for acute and chronic illnesses, sterile intravenous solutions, generic injectable medications, parenteral nutrition therapies, infusion systems, devices, inhaled anesthetics, and surgical hemostat and sealant products are among the company's product and service offerings. Hospitals, rehabilitation facilities, kidney dialysis clinics, nursing homes, and patient's homes all use the company's products. Baxter distributes its goods through a network of independent distributors, medication wholesalers, specialty pharmacies, and other providers of alternate sites, in addition to its direct sales staff. In addition to the Americas, the Middle East, Africa, Europe, and Asia-Pacific, the corporation operates in these regions. The US city of Deerfield, Illinois, serves as the headquarters of Baxter.

Gerresheimer AG s a supplier of specialty glass and plastic products for the pharmaceutical and healthcare sectors. Plastic systems, tubular glass, and molded glass items such vials, ampoules, cartridges, glass syringes, glass bottles and jars, polyethylene (PET) bottles, tablet containers, Erlenmeyer flasks, and plastic containers are all part of its product line. Additionally, it offers customers in the personal care and food and beverage industries cosmetics glass and finishing, as well as various packaging solutions and application systems. Gerresheimer sells its goods under a few brands: ClearJect, Duma, Gx Tekion, Gx TELC, Gx RHOC, Gx THOR, Gx FLASH, and Gx RTF. The corporation has manufacturing sites in Asia, North America, Europe, and South America. In North Rhine-Westphalia, Germany, Dusseldorf serves as the company's headquarters.

Key Companies in the Pharmaceutical Cartridges market include

• Ambica Pharma Machines Pvt. Ltd.


• AptarGroup Inc.


• Baxter International Inc.


• Camfil AB


• Datwyler Holding Inc.


• Gerresheimer AG


• groninger and Co. gmbh


• Hubena


• Kalbag Filters Pvt. Ltd.


• KEL INDIA FILTERS


• Maquinaria Industrial Dara SL


• Merck KGaA


• Nipro Corp.


• SCHOTT AG


• SGD S.A.

Pharmaceutical Cartridges Industry Developments

March 2022 TruPharma, LLC and its development and commercial partner Sage Chemical, Inc. announced that the U.S. Food and Drug Administration (FDA) had approved Abbreviated New Drug Application (ANDA) for generic apomorphine hydrochloride cartridges, 30 mg/3 mL (10 mg/mL).

May 2022 CHOTT will announce an investment of one million Euros in cartridge manufacturing. In a nest/tub or tray configuration, SCHOTT can deliver these cartridges cleansed, siliconized, crimped, and pre-sterilized. This enables pharmaceutical companies to promptly begin the drug-filling process without washing, siliconizing, or sterilizing the containers themselves.

November 2022 Recipharm, a global CDMO, has invested in a new high-speed filling line for prefilled syringes and cartridges at its Wasserburg, Germany, facility in response to rising customer demand for these high-growth fill formats.

Pharmaceutical Cartridges Market Segmentation

Pharmaceutical Cartridges Material Outlook

• Glass


• Plastic

Pharmaceutical Cartridges Capacity Outlook

• Below 5 ml


• 5-50 ml


• 51-250 ml


• Above 250 ml

Pharmaceutical Cartridges Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America